NCT07541443

Brief Summary

Common mental health disorders, like anxiety and depression, are widespread among the American population. The prevalence of mental health disorders among adults continues has consistently increased from previous decades and is now a major public health challenge. Data shows that 1 in 5 Americans regularly report feeling depressed. Therapy is supported as an effective means of treating mental anxiety and depression, and lessening their severity. But therapy is expensive and not always covered by insurance. It is well known that exercise provides physiological and psychological benefits to those suffering from mental health disorders. However, prescribing and monitoring exercise can be challenging, if not impossible, for mental health practitioners, and individuals often are unsure how to begin an exercise program on their own. Studies that have investigated the impact on exercise on mental health have delivered exercise using a traditional clinical trial exercise structure, where exercise is completed by the client/patient under the supervision of a professional. This structure, while beneficial, does not always transfer well to real-world settings. Working one-on-one with an exercise professional poses financial and scheduling barriers for most. Few, if any, studies have used group exercise and group therapy to address mental health concerns. This study aims to combine cardiovascular exercise with group therapy to investigate the impact of cardiovascular fitness on mental health outcomes among Rural dwelling adults living with generalized anxiety and/or depressive disorders.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Jun 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2026

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 21, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2026

11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

7 months

First QC Date

March 30, 2026

Last Update Submit

April 14, 2026

Conditions

Keywords

cardiovascular fitnessmental healthanxietydepressiongroup exercise

Outcome Measures

Primary Outcomes (2)

  • Aim 1a. Evaluate the impact of a structured group cardiovascular exercise and CBT program on anxiety symptoms as measured by scores on the PHQ-9 assessment.

    Exercise is associated with positive mental health outcomes. The investigators hypothesize that participants in the combined cardiovascular and CBT program will see improvements on the PHQ-9 assessment.

    8 weeks

  • Aim 1b. Investigate the impacts of a structured group cardiovascular exercise and CBT program on depressive symptoms as measured by scores on the GAD-7 assessment.

    Exercise is associated with positive mental health outcomes. The investigators hypothesize that participants in the combined cardiovascular and CBT program will see improvements on the GAD-7 assessment.

    8 weeks

Secondary Outcomes (3)

  • Aim 2. Determine the impact of a structured group cardiovascular exercise and CBT program on cardiovascular fitness, reported as VO2max.

    8 weeks

  • Aim 3a. Determine the relationship between cardiovascular fitness and anxiety symptoms, reported as scores on the PHQ-9 assessment.

    8 weeks

  • Aim 3b. Determine the relationship between cardiovascular fitness and depressive symptoms, reported as scores on the GAD-7 assessment.

    8 weeks

Study Arms (1)

Group Cardiovascular Exercise

EXPERIMENTAL

Participants will complete an 8-week walking/jogging + CBT exercise training program, led by the research team. The twice weekly sessions will focus on teaching individuals living with anxiety and depression how to incorporate regular cardiovascular exercise into their daily lives to benefit their mental health. Sessions will include 45-60 minutes of structured walking and/or jogging and Cognitive Behavioral Therapy (CBT) exercises led by a trained practitioner (LPC). Participants will be encouraged to attend a minimum of two (2) group cardiovascular exercise sessions weekly for the duration of the 8-week study.

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Adults (ages 18 years +) living in Rural Kansas will be recruited to participate in a cardiovascular exercise group via referral from their mental health practitioner (clinical psychologist or clinical counselor). Only participants with a diagnosis of generalized anxiety and/or a depressive disorder will be enrolled to participate in this study. Participants will complete a cardiovascular fitness assessment (VO2submax) via a field test, the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Screening Instrument (GAD-7). Participants will then be asked to complete twice weekly group walking and jogging sessions, coupled with short CBT activities. Sessions will include 45-60 minutes of structured walking and/or jogging and Cognitive Behavioral Therapy (CBT) exercises led by a trained practitioner (LPC and GRA in Clinical Psychology). Upon completion of the 8-week group exercise + CBT intervention, all assessments will be completed again and data analyzed.

Group Cardiovascular Exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+ years
  • Generalized anxiety and/or depressive disorder diagnosis
  • Able to exercise without use of ambulatory device
  • Willing and able to attend a minimum of 2 group exercise sessions weekly

You may not qualify if:

  • Myocardial infarction or symptoms of coronary artery disease in the last 2yrs
  • Uncontrolled hypertension within the last 6 months
  • Cancer in the last 2yrs (except non-metastatic basal or squamous cell carcinoma)
  • Significant pain or musculoskeletal disorder that would prohibit participation in an exercise program
  • Possible/probably dementia or mild cognitive impairment (MCI) base on adjudication
  • Physician concern regarding safety or completion of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Generalized Anxiety DisorderAnxiety DisordersPsychological Well-BeingDepression

Interventions

Exercise

Condition Hierarchy (Ancestors)

Mental DisordersPersonal SatisfactionBehaviorBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Steven E Blocker Jr, MS, LPC

    Emporia State University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Erin M Blocker, PhD

CONTACT

Mason Bina, BS - Graduate Research Asst.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 30, 2026

First Posted

April 21, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 20, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

The investigators do not plan to share individual participant data (IPD), including de-identified datasets, with researchers outside of the IRB-approved study team. Access to participant-level data will be restricted to authorized members of the research team as approved by the Institutional Review Board. Only aggregate, summary-level results will be disseminated through peer-reviewed publications, conference presentations, and other scholarly or public dissemination outlets upon completion of the study. No individual-level data will be made publicly available.